Thursday, October 8, 2026
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Gentry George Teng King, MD
Fred Hutchinson Cancer Center, University of Washington
Published Articles (2)
Precision Frontiers in Hepatobiliary Oncology: FGFR2 Selectivity and Immunotherapy in HCC and iCCA
March 24, 2026
Expert analysis of FGFR2-targeted therapy in intrahepatic cholangiocarcinoma and the evolving role of immunotherapy in hepatocellular carcinoma, from adjuvant setbacks to perioperative and first-line advances.